Outputs (18)

Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study (2015)
Journal Article
Ban, L., Tata, L. J., Humes, D., Fiaschi, L., & Card, T. R. (2015). Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study. Alimentary Pharmacology and Therapeutics, 42(7), https://doi.org/10.1111/apt.13354

Background: Clinical studies have reported reduced fertility in women with inflammatory bowel disease (IBD).

Aim: To compare fertility rates in women with IBD to those in women without IBD and assess whether the relative fertility differed followi... Read More about Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study.

Congenital anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: a population-based cohort study (2015)
Journal Article
Ban, L., Fleming, K. M., Doyle, P., Smeeth, L., Hubbard, R. B., Fiaschi, L., & Tata, L. J. (2015). Congenital anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: a population-based cohort study. PLoS ONE, 10(7), Article 131130. https://doi.org/10.1371/journal.pone.0131130

BACKGROUND: Antenatal antiepileptic drug (AED) use has been found to be associated with increased major congenital anomaly (CA) risks. However whether such AED-associated risks were different according to periconceptional high dose (5mg daily) folic... Read More about Congenital anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: a population-based cohort study.

Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring (2015)
Journal Article
Dhalwani, N. N., Szatkowski, L., Coleman, T., Fiaschi, L., & Tata, L. J. (2015). Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics, 135(5), https://doi.org/10.1542/peds.2014-2560

BACKGROUND AND OBJECTIVES: Nicotine replacement therapy (NRT) is now being used as a smoking cessation aid during pregnancy, although little is known about fetal safety. We assessed the relationship between early pregnancy exposure to NRT or smoking... Read More about Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring.

A comparison of UK primary care data with other national data sources for monitoring the prevalence of smoking during pregnancy (2014)
Journal Article
Dhalwani, N. N., Tata, L. J., Coleman, T., Fiaschi, L., & Szatkowski, L. (2015). A comparison of UK primary care data with other national data sources for monitoring the prevalence of smoking during pregnancy. Journal of Public Health, 37(3), 547-554. https://doi.org/10.1093/pubmed/fdu060

Background: We aimed to assess the potential usefulness of primary care data for estimating smoking prevalence in pregnancy by comparing the primary care data estimates with those obtained from other data sources.
Methods: In The Health Improvement... Read More about A comparison of UK primary care data with other national data sources for monitoring the prevalence of smoking during pregnancy.

Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data (2014)
Journal Article
Dhalwani, N. N., Szatkowski, L., Coleman, T., Fiaschi, L., & Tata, L. J. (2014). Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data. British Journal of General Practice, Article e554-e560. https://doi.org/10.3399/bjgp14X681361

Background Licensing arrangements for nicotine replacement therapy (NRT) in the UK were broadened in 2005 to allow prescribing to pregnant smokers. However, estimates of NRT prescribing in pregnant females in the UK are currently lacking.


Aim To... Read More about Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data.

First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study (2014)
Journal Article
Ban, L., West, J., Gibson, J. E., Fiaschi, L., Sokal, R., Doyle, P., Hubbard, R., Smeeth, L., & Tata, L. J. (2014). First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study. PLoS ONE, 9(6), Article e100996. https://doi.org/10.1371/journal.pone.0100996

BACKGROUND: Despite their widespread use the effects of taking benzodiazepines and non-benzodiazepine hypnotics during pregnancy on the risk of major congenital anomaly (MCA) are uncertain. The objectives were to estimate absolute and relative risks... Read More about First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study (2014)
Journal Article
Ban, L., Gibson, J. E., West, J., Fiaschi, L., Sokal, R., Smeeth, L., Doyle, P., Hubbard, R. B., & Tata, L. J. (in press). Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG: An International Journal of Obstetrics and Gynaecology, 121(12), https://doi.org/10.1111/1471-0528.12682

OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study.... Read More about Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.

Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications (2013)
Journal Article
Ban, L., Tata, L. J., Fiaschi, L., & Card, T. R. (2014). Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. Gastroenterology, 146(1), https://doi.org/10.1053/j.gastro.2013.09.061

Background & aims: Concerns persist about the risk of major congenital anomalies in children of women with inflammatory bowel disease (IBD), and whether medication use affects risk. We assessed these risks, and variations in use of medications by wom... Read More about Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.